Luu Brendan (CIK 1842369) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-13). Recent activity: Buy ENTA (1,575 shares), Buy ENTA (4,987 shares), Sell ENTA (3,257 shares), Sell ENTA (1,394 shares), Sell ENTA (498 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | Buy | 1,575 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | Buy | 4,987 | $0 |
| 2026-02-13 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | Sell | 3,257 | $46,412 |
| 2025-12-05 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | Sell | 1,394 | $19,837 |
| 2025-12-03 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | Sell | 498 | $7,032 |
| 2025-02-14 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | Buy | 7,500 | $0 |
| 2025-02-14 | ENANTA PHARMACEUTICALS INC (ENTA) | Chief Business Officer | Sell | 3,326 | $18,592 |
Source: SEC Form 4 filings · as of 2026-02-13